Trial Information
Non-Invasive Prediction of Colorectal Neoplasia
Inclusion Criteria:
- ability to complete a consent form
- must be at above average risk for colorectal neoplasia
- physically able to undergo colonoscopy or barium enema
Exclusion Criteria:
- Mentally handicapped
- Physically infirm
- Low risk for colorectal neoplasia
- Pregnant individuals
- Vulnerable populations
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Correlation of Adnab-9 stool result with outcome of colonoscopy
Outcome Description:
Stool is collected on guaiac stool cards and/or stool Polymedco sample bottle and extracted. Extracted stool is assayed for protein content and this is used as a standard for the Adnab-9 ELISA. Record review note colonoscopy outcome which is correlated with Adnab-9 ELISA result.
Outcome Time Frame:
10 years
Safety Issue:
No
Principal Investigator
Martin Tobi, MB,ChB
Investigator Role:
Principal Investigator
Investigator Affiliation:
Philadelphia VAMC
Authority:
United States: Federal Government
Study ID:
00919
NCT ID:
NCT01815463
Start Date:
August 2006
Completion Date:
March 2015
Related Keywords:
- Colonic Polyps
- Polyposis Coli
- Colorectal Cancer
- stool
- monoclonal antibody
- Adnab-9
- FOBT
- FIT
- iFOBT
- colonoscopy
- barium enema
- flexible sigmoidoscopy
- Neoplasms
- Colonic Polyps
- Colorectal Neoplasms
- Adenomatous Polyposis Coli
Name | Location |
Philadelphia VAMC |
Philadelphia, Pennsylvania 19104 |